Skip to content

Effect of acute nitrate supplementation on neurovascular coupling and cognitive performance in hypoxia.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
Feb 2016
Citations: 31
Influential: 2
Interventional (Human) Studies
92

What this study found

Salivary nitrite increased with nitrate during hypoxia (2.7 ± 1.0 AU) vs placebo (0.2 ± 0.3 AU; p<0.001). Neurovascular coupling (change in MCA mean velocity during Stroop) increased during Stroop in both normoxia and hypoxia, with no difference between nitrate and placebo in either condition. Hypoxia reduced memory performance by about 6 points (SD 13; p<0.05) while other cognitive domains remained unchanged. Overall, acute nitrate supplementation did not alter NVC or cognitive performance during hypoxia in young healthy men. Practical takeaway: acute dietary nitrate at this dose is not an…

Study & population
Randomized, double-blind, crossover trial; 20 healthy, recreationally active men; mean age 23 ± 3 years.
Intervention
Single acute dose of nitrate (0.45 g nitrate) as Beet It Sports Shot, 70 mL, taken immediately before ~105 minutes of normobaric hypoxia (FiO2 11.6%).
Key limitation
Limitations include a young, healthy male sample limiting generalizability; acute, single-dose exposure; lack of data in women or older individuals; and testing limited to select vascular and cognitive measures.
View sourceOpen PDF

Original abstract

The matching of oxygen supply to neural demand (i.e., neurovascular coupling (NVC)) is an important determinant of cognitive performance. The impact of hypoxia on NVC remains poorly characterized. NVC is partially modulated by nitric oxide (NO), which may initially decrease in hypoxia. This study investigated the effect of acute NO-donor (nitrate) supplementation on NVC and cognitive function in hypoxia. Twenty healthy men participated in this randomized, double-blind, crossover design study. Following normoxic cognitive/NVC testing, participants consumed either nitrate (NIT) or a NIT-depleted placebo (PLA). Participants then underwent 120 min of hypoxia (11.6% ± 0.1% O2) and all cognitive/NVC testing was repeated. NVC was assessed as change in middle cerebral artery (MCA) blood flow during a cognitive task (incongruent Stroop) using transcranial Doppler. Additional computerized cognitive testing was conducted separately to assess memory, executive function, attention, sensorimotor, and social cognition domains. Salivary nitrite significantly increased following supplementation in hypoxia for NIT (+2.6 ± 1.0 arbitrary units (AU)) compared with PLA (+0.2 ± 0.3 AU; p < 0.05). Memory performance (-6 ± 13 correct) significantly decreased (p < 0.05) in hypoxia while all other cognitive domains were unchanged in hypoxia for both PLA and NIT conditions (p > 0.05). MCA flow increased during Stroop similarly in normoxia (PLA +5 ± 6 cm·s(-1), NIT +7 ± 7 cm·s(-1)) and hypoxia (PLA +5 ± 9 cm·s(-1), NIT +6 ± 7 cm·s(-1)) (p < 0.05) and this increase was not altered by PLA or NIT (p > 0.05). In conclusion, acute hypoxia resulted in significant reductions in memory concomitant with preservation of executive function, attention, and sensorimotor function. Hypoxia had no effect on NVC. Acute NIT supplementation had no effect on NVC or cognitive performance in hypoxia.